595 related articles for article (PubMed ID: 12664378)
1. Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma.
Guex-Crosier Y; Chamot L; Zografos L
Klin Monbl Augenheilkd; 2003 Mar; 220(3):193-5. PubMed ID: 12664378
[TBL] [Abstract][Full Text] [Related]
2. [BCG infection of the glans penis after intravesical BCG therapy].
Michelet N; Spenatto N; Viraben R; Cuny JF; Mazet J; Trechot P; Barbaud A; Schmutz JL
Ann Dermatol Venereol; 2008; 135(6-7):479-83. PubMed ID: 18598797
[TBL] [Abstract][Full Text] [Related]
3. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
[TBL] [Abstract][Full Text] [Related]
4. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of intravesical bacillus Calmette-Guerin for carcinoma in situ: relationship of progression to histological response and p53 nuclear accumulation.
Ovesen H; Horn T; Steven K
J Urol; 1997 May; 157(5):1655-9. PubMed ID: 9112499
[TBL] [Abstract][Full Text] [Related]
6. Transient anuria requiring nephrostomy after intravesical bacillus Calmette-Guérin instillations for superficial bladder cancer.
Kaneko T; Fujita K; Homma Y
Int J Urol; 2006 Mar; 13(3):294-5. PubMed ID: 16643629
[TBL] [Abstract][Full Text] [Related]
7. Intravesical instillations with bacillus calmette-guérin for the treatment of carcinoma in situ involving prostatic ducts.
Palou Redorta J; Schatteman P; Huguet Pérez J; Segarra Tomás J; Rosales Bordes A; Algaba F; Villavicencio Mavrich H
Eur Urol; 2006 May; 49(5):834-8; discussion 838. PubMed ID: 16426729
[TBL] [Abstract][Full Text] [Related]
8. A CASE OF INTRAVESICAL BACILLUS CALMETTE-GUERIN-RELATED ENDOPHTHALMITIS AND RETINITIS CONFIRMED WITH RETINAL BIOPSY.
Huggins A; Adam M; Ehmann D; Eagle RC; Malloy B; Garg SJ
Retin Cases Brief Rep; 2019; 13(4):333-336. PubMed ID: 28644177
[TBL] [Abstract][Full Text] [Related]
9. Granulomatous balanoposthitis after intravesical Bacillus-Calmette-Guerin instillation therapy.
Yusuke H; Yoshinori H; Kenichi M; Akio H
Int J Urol; 2006 Oct; 13(10):1361-3. PubMed ID: 17010022
[TBL] [Abstract][Full Text] [Related]
10. [Intravesical Bacillus Calmette-Guerin (BCG: Tokyo 172 strain) instillation for carcinoma in situ of the bladder: results with 6 successive instillations of 40 mg BCG].
Mugiya S; Nagata M; Takayama T; Ozono S; Ito T; Maruyama S; Hadano S; Nagae H
Hinyokika Kiyo; 2004 Jul; 50(7):469-73. PubMed ID: 15334890
[TBL] [Abstract][Full Text] [Related]
11. Refractory arthropathy after intravesical bacillus Calmette-Guérin therapy. Usefulness of isoniazide.
Milas L; Maillefert JF; Michel F; Piroth C; Wautot A; Tavernier C
Rev Rhum Engl Ed; 1999 Feb; 66(2):106-8. PubMed ID: 10084171
[TBL] [Abstract][Full Text] [Related]
12. Low dose bacillus Calmette-Guerin for carcinoma in situ of the bladder: long-term results.
Losa A; Hurle R; Lembo A
J Urol; 2000 Jan; 163(1):68-71; discussion 71-2. PubMed ID: 10604316
[TBL] [Abstract][Full Text] [Related]
13. Intravesical bacillus Calmette-Guèrin therapy: experience with a reduced dwell-time in patients with pronounced side-effects.
Andius P; Fehrling M; Holmäng S
BJU Int; 2005 Dec; 96(9):1290-3. PubMed ID: 16287447
[TBL] [Abstract][Full Text] [Related]
14. Treatment of carcinoma in situ with intravesical bacillus Calmette-Guerin without maintenance.
Griffiths TR; Charlton M; Neal DE; Powell PH
J Urol; 2002 Jun; 167(6):2408-12. PubMed ID: 11992047
[TBL] [Abstract][Full Text] [Related]
15. Urinary interleukin-2 may predict clinical outcome of intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the bladder.
Watanabe E; Matsuyama H; Matsuda K; Ohmi C; Tei Y; Yoshihiro S; Ohmoto Y; Naito K
Cancer Immunol Immunother; 2003 Aug; 52(8):481-6. PubMed ID: 12707736
[TBL] [Abstract][Full Text] [Related]
16. [Two cases of successful treatments with steroid for local and systemic hypersensitivity reaction following intravesical instillation of Bacillus Calmette-Guerin].
Shimasaki N; Yamasaki I; Kamada M; Syuin T
Hinyokika Kiyo; 2001 Apr; 47(4):281-4. PubMed ID: 11411106
[TBL] [Abstract][Full Text] [Related]
17. [Is second course intravesical Bacillus Calmette-Guerin therapy for recurrent carcinoma in situ of the bladder useful?].
Yamada Y; Hara I; Kumano M; Furukawa J; Yamanaka K; Kamidono S
Hinyokika Kiyo; 2005 Aug; 51(8):539-43. PubMed ID: 16164270
[TBL] [Abstract][Full Text] [Related]
18. Prostatorectal fistula following intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the urinary bladder.
Enatsu N; Ota T; Ochi A
Int J Urol; 2010 Sep; 17(9):822-3. PubMed ID: 20727055
[No Abstract] [Full Text] [Related]
19. [Bilateral tuberculous epididymitis after intravesical Bacillus Calmette-Guerin therapy].
Shigehara K; Kobori Y; Amano T; Takemae K
Hinyokika Kiyo; 2005 Dec; 51(12):839-42. PubMed ID: 16440736
[TBL] [Abstract][Full Text] [Related]
20. Bacillus Calmette-Guerin versus epirubicin for primary, secondary or concurrent carcinoma in situ of the bladder: results of a European Organization for the Research and Treatment of Cancer--Genito-Urinary Group Phase III Trial (30906).
de Reijke TM; Kurth KH; Sylvester RJ; Hall RR; Brausi M; van de Beek K; Landsoght KE; Carpentier P;
J Urol; 2005 Feb; 173(2):405-9. PubMed ID: 15643181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
